CYCN stock

Cyclerion Therapeutics Inc (CYCN) financials · $8.6M cap

Cyclerion Therapeutics Inc (CYCN) $8.6M cap.

Cached annual income statement
LineFY2025FY2024
Revenue$2.1M$2.0M
Cost of Revenue$0$0
Gross Profit$0$0
Operating Income-$5.0M-$3.6M
Net Income-$3.5M-$3.1M
EPS (Diluted)$-1.11$-1.21
Cached annual balance sheet
LineFY2025FY2024
Total Assets$10.0M$9.6M
Current Assets$4.6M$4.2M
Cash & Equivalents$3.2M$3.2M
Inventory$0$0
PP&E$0$0
Total Liabilities$10.0M$9.6M
Current Liabilities$900.0K$725.0K
Short-term Debt$0$0
Long-term Debt$0$0
Total Debt$0$0
Shareholders' Equity$9.1M$8.8M
Retained Earnings-$271.0M-$267.5M
Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow-$3.3M-$4.3M
CapEx$0$0
Investing Cash Flow$0$0
Financing Cash Flow$3.3M$0
Dividends Paid$0$0
Net Change in Cash$8.0K$0
Free Cash Flow$0$0

FAQ

What is CYCN P/E and revenue?

Cyclerion Therapeutics Inc (CYCN) $8.6M cap.

What is CYCN revenue?

Cyclerion Therapeutics Inc last cached revenue is $2.1M (FY2025).

Is CYCN profitable?

Cyclerion Therapeutics Inc last cached net income is -$3.5M.

What are CYCN total assets?

Cyclerion Therapeutics Inc last cached total assets are $10.0M.

What is CYCN free cash flow?

Cyclerion Therapeutics Inc last cached free cash flow is $0.

Not investment advice. Cached statements, not a live tape.